We use cookies to improve your experience on this website. Read More Allow Cookies

Latest News From BioPharmaChem

    August 2019

  • NEW MSD CARLOW FACILITY GRANTED FULL PLANNING PERMISSION

    NEW MSD CARLOW FACILITY GRANTED FULL PLANNING PERMISSION

    01 August, 2019

    It was announced yesterday that MSD will construct a new 13,000 square metre facility on a site adjacent to MSD’s existing Carlow plant. The facility will focus on the production of vaccines and biologics.It is scheduled to commence manufacturing operations in 2022 and will employ an additional 170 staff and 100 contractor staff when operational. The build phase will also see approximately 700 tradespeople employed on site.

    Continue Reading »

  • Uniphar completes £24m acquisition of Durbin

    Uniphar completes £24m acquisition of Durbin

    05 August, 2019

    Irish healthcare services company Uniphar said it had completed the acquisition of Durbin, a specialist supplier of pharmaceuticals based in the US and UK. Durbin, which supplies more than 160 countries, will be integrated into Uniphar’s Product Access division, growing the unit to more than 170 employees and managing access programmes for 36 global manufacturers, from offices in Ireland, the UK and the US.

    Continue Reading »